Gujarat Pharmalab Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-06-2024
- Paid Up Capital ₹ 2.50 M
as on 19-06-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 19-06-2024
- Satisfied Charges ₹ 3.20 M
as on 19-06-2024
- Revenue %
(FY 2022)
- Profit 375.82%
(FY 2022)
- Ebitda 124.69%
(FY 2022)
- Net Worth 12.63%
(FY 2022)
- Total Assets -6.98%
(FY 2022)
About Gujarat Pharmalab
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹3.20 M, as per Ministry of Corporate Affairs (MCA) records.
Chetankumar Domadia and Valjibhai Domadia serve as directors at the Company.
- CIN/LLPIN
U24231GJ2000PTC038890
- Company No.
038890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gujarat Pharmalab Private Limited offer?
Gujarat Pharmalab Private Limited offers a wide range of products and services, including Common Disease Medicines, Anti Acne Drug, Dentist Tools, Equipment & Supplies, Oral Care Kit, Chemical Reagents & Catalysts, Potassium Salts, Pharmaceutical Syrup, Cosmetics, Hair & Beauty Products, Body Care Products, Pharmaceutical Medicine.
Who are the key members and board of directors at Gujarat Pharmalab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetankumar Domadia  | Director | 10-Nov-2017 | Current |
Valjibhai Domadia  | Director | 16-Oct-2012 | Current |
Financial Performance of Gujarat Pharmalab.
Gujarat Pharmalab Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 375.82% increase in profit. The company's net worth Soared by an impressive increase of 12.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gujarat Pharmalab?
In 2018, Gujarat Pharmalab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Feb 2024 | ₹1.00 Cr | Open |
Canara Bank Creation Date: 27 Apr 2006 | ₹0.20 M | Satisfied |
Canara Bank Creation Date: 19 Feb 2004 | ₹3.00 M | Satisfied |
How Many Employees Work at Gujarat Pharmalab?
Gujarat Pharmalab has a workforce of 26 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujarat Pharmalab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujarat Pharmalab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
